DOCSLIB.ORG

Role of Ubiquitin and SUMO in Intracellular Trafficking

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Role of Ubiquitin and SUMO in Intracellular Trafficking Curr. Issues Mol. Biol. (2020) 35: 99-108. Role of Ubiquitin and SUMO in Intracellular Trafcking Maria Sundvall1,2,3* 1Institute of Biomedicine, University of Turku, Turku, Finland. 2Western Cancer Centre FICAN West, Turku University Hospital, Turku, Finland. 3Department of Oncology and Radiotherapy, University of Turku, Turku, Finland. *Correspondence: [email protected] htps://doi.org/10.21775/cimb.035.099 Abstract behaviour. In addition to e.g. chemical groups, Precise location of proteins at a given time within such as phosphate groups, proteins can be modi- a cell is essential to convey specifc signals and fed by small polypeptides, such as ubiquitin and result in a relevant functional outcome. Small SUMO. Ubiquitin and SUMO share a similar ubiquitin-like modifcations, such as ubiquitin three-dimensional structure and are principally and SUMO, represent a delicate and diverse way covalently linked at lysine (K) residues of sub- to transiently regulate intracellular trafcking strate proteins by a similar conjugation pathway events of existing proteins in cells. Trafcking (Hershko et al., 1998; Hay, 2013). Unlike ubiq- of multiple proteins is controlled reversibly by uitin, SUMO is preferentially atached at SUMO ubiquitin and/or SUMO directly or indirectly via consensus sites ΨKxE in substrates Ψ = hydropho- regulation of transport machinery components. bic residue with high preference for I or V, x = any Regulation is dynamic and multilayered, involv- amino acid) under steady state conditions, but ing active crosstalk and interdependence between under stress conditions in particular more non- post-translational modifcations. However, in consensus sites are SUMOylated (Hendriks et al., most cases regulation appears very complex, and 2016). Mammals express ubiquitously SUMO1, the mechanistic details regarding how ubiquitin SUMO2 and SUMO3, whereas SUMO4 and and SUMO control protein location in cells are SUMO5 are only expressed in some tissues and not yet fully understood. Moreover, most of the their functional role is unclear (Pichler et al., fndings still lack in vivo evidence in multicellular 2017). SUMO2 and SUMO3 are nearly identi- organisms. cal and resemble approximately 50% to SUMO1 (Geiss-Friedlander et al., 2007). Precursors of ubiquitin and SUMO are pro- Posttranslational modifcations cessed to mature forms prior to conjugation and in regulation of cellular activated by an E1 enzyme in a reaction depend- processes ing on ATP. Subsequently ubiquitin and SUMO are transferred to an E2 enzyme, and E3 ligase General principles of ubiquitination alone or with E2 ligates them to substrates by and SUMOylation an isopeptide bond (Hershko et al., 1998; Hay, Postranslational modifcation (PTM) of pro- 2013). Modifcation is reversible and specifc teins is a powerful, fast and ofen transient way proteases can cleave ubiquitin and SUMO from to control the fate of existing proteins and cell substrates (Williamson et al., 2013; Kunz et al., caister.com/cimb 99 Curr. Issues Mol. Biol. Vol. 35 304 | Sundvall 2018). Proteins can be tagged by a single ubiqui- E1 (Sae1/Aos1–Sae2/Uba2) and E2 (Ubc9) tin or SUMO either at one or at multiple lysines. are known to be involved in SUMO conjugation In addition, modifcations can exist as chains. (Hay, 2013). Tree classes of SUMO E3s have Ubiquitin contains seven internal lysine residues been widely accepted and characterized including (K6, K11, K27, K29, K33, K48, K63) that are SP-RING Siz/PIAS ligases, RanBP2 and ZNF451 involved in the formation of ubiquitin-ubiquitin ligases (Geiss-Friedlander et al., 2007; Rytinki et polymers, known as polyubiquitin chains (Pickart al., 2009; Cappadocia et al., 2015). Both E2 and et al., 2004; Heride et al., 2014). In addition, the E3 can select substrates for SUMOylation, and linkage between the amino-terminal amino group spatial and temporal regulation of co-localization of methionine on a ubiquitin can be conjugated appears integral for substrate selection (Pichler with a target protein and the carboxy-terminal et al., 2017). Cysteine proteases of the sentrin- carboxy group of the incoming ubiquitin for specifc protease (SENP) family members reverse linear chains (Walczak et al., 2012). SUMOs SUMO conjugation in mammals (Kunz et al., can also form polymeric chains through internal 2018). Moreover, desumoylating isopeptides 1 lysine residues (Geiss-Friedlander et al., 2007). and 2 and ubiquitin-specifc protease-like 1 can Monoubiquitination and diferent chain types deSUMOylate proteins (Shin et al., 2012; Schulz et determine the fate of the modifed protein (Piper al., 2012). Whereas ubiquitin machinery is widely et al., 2014). For example, K48 ubiquitin chains expressed within a cell, components of SUMO are considered classical signals for proteasomal conjugation pathway mainly localize at the nuclear degradation and K63 ubiquitin chains are linked pores and nucleus. Tus, most of SUMOylated to trafcking and DNA damage response (Pick- substrates are nuclear proteins, although SUMO art et al., 2004). Recently basic principles of the modifed proteins outside of nucleus exist (Geiss- feld have been challenged by e.g. discoveries of Friedlander et al., 2007). mixed polyubiquitin chains and ubiquitination of Ubiquitination is regulated by extracellular non-lysine residues (Piper et al., 2014). Less is stimuli including growth factors and cytokines, known regarding the consequences of atachment stress and cell cycle changes (Pickart et al., 2004; of either single or many SUMO moieties. SUMO Heride et al., 2014). Diferent types of stress stimuli chains are at least implicated in recruitment of such as heat shock, hypoxia, reactive oxygen spe- SUMO-targeted ubiquitin ligases (Lallemand- cies, DNA damage and proteotoxic stress regulate Breitenbach et al., 2008). the activity of SUMOylation machinery (Hieta- kangas et al., 2003; Shao et al., 2004; Bossis et al., Components, regulation and function 2006; Galanty et al., 2009; Morris et al., 2009; of ubiquitin and SUMO machinery Seifert et al., 2015). Both ubiquitin and SUMO Multiple enzymes involved in ubiquitin conjuga- modifcations can alter the function, activity, loca- tion have been recognized. Te human ubiquitin tion and stability of their targets. Ubiquitin and machinery comprises a network including two SUMO are recognized by either ubiquitin-binding ubiquitin E1 enzymes, approximately 40 ubiquitin domains (UBD) or sumo-interacting domains E2s, and more than 600 E3 ubiquitin ligases in (SIM), respectively, and serve as platforms for the human genome (Heride et al., 2014). Tree non-covalent protein–protein interactions (Seet major types of E3 ligases are really interesting et al., 2006). Tese domains have been identi- new gene (RING) type E3s comprising most fed in hundreds of proteins. PTMs are also of human E3s, homologous to E6-AP carboxyl involved in regulation of conjugation specifcity terminus (HECT) and RING-between-RING and activation (Pichler et al., 2017). For example, (RBR) E3s ligases (Deshaies et al., 2009; Rotin SUMO-targeted ubiquitin ligase (STUbL) RNF4 et al., 2009; Wenzel et al., 2012). Ubiquitin is contains multiple SIMs and a RING-domain to cleaved by approximately 100 deubiquitinating bind SUMOylated proteins and an E2 ubiquitin- enzymes (DUBs) (Williamson et al., 2013; Heride conjugation enzyme (Sun et al., 2007; Tatham et et al., 2014). Intriguingly, only one heterodimeric al., 2008). caister.com/cimb 100 Curr. Issues Mol. Biol. Vol. 35 Ubiquitin and SUMO in Intracellular Trafcking | 305 Ubiquitin and SUMO as signals epsin and endosomal sortin complex required for regulating membrane trafcking transport (ESCRT) (Piper et al., 2014). Ubiquitin and endocytosis is also indirectly involved in control of endocytosis as components of endocytic machinery are actively General principles of membrane regulated by ubiquitination (Piper et al., 2014). protein trafcking and endocytosis in SUMOylation has been implicated in the cells regulation of endocytic processes, although Internalization and endocytosis of cell surface when compared to ubiquitin the evidence is less proteins including diferent receptors ofen occurs extensive, and more work is needed to make general via the clathrin-dependent endocytic pathway. conclusions. Nevertheless, endocytosis of kainate Cell surface receptors are clustered to pits coated receptor GluR6 is regulated by SUMOylation with clathrin that pinch of of the membrane and non-SUMOylated mutant of GluR6, GluR6- forming vesicles and early endosomes. From early K886R, is endocytosis-impaired due to unknown endosomes cargo can be directed back to plasma mechanisms (Martin et al., 2007). SUMOylation membrane via recycling endosomes or destined to of Smoothened (Smo) promotes its localization lysosomal degradation via late endosomes and mul- at the cell surface (Ma et al., 2016). Intriguingly, tivesicular bodies (Mellman and Yarden, 2013). mechanistically SUMO interferes with efcient Smo Also, other types of endocytic routes exist, includ- ubiquitination by recruiting deubiquitinase UBPY/ ing cholesterol-rich membrane structures, such USP8 in a SIM-dependent manner (Ma et al., 2016). as lipid rafs and caveolae (Barbieri et al., 2016). SUMOylation regulates also cell surface expression Several adaptor proteins and PTMs control these and activity of VEGFR2 receptor tyrosine kinase processes (Piper et al., 2014). Membrane protein (Zhou et al., 2018). VEGFR2–SUMO1 fusion trafcking and endocytosis system are tightly con- protein but not SUMOylation defective mutant nected
Load more

Recommended publications
  • Isoform-Specific Monobody Inhibitors of Small Ubiquitin-Related Modifiers Engineered Using Structure-Guided Library Design
    Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design Ryan N. Gilbretha, Khue Truongb, Ikenna Madub, Akiko Koidea, John B. Wojcika, Nan-Sheng Lia, Joseph A. Piccirillia,c, Yuan Chenb, and Shohei Koidea,1 aDepartment of Biochemistry and Molecular Biology, and cDepartment of Chemistry, University of Chicago, 929 East 57th Street, Chicago, IL 60637; and bDepartment of Molecular Medicine, Beckman Research Institute of the City of Hope, 1450 East Duarte Road, Duarte, CA 91010 Edited by David Baker, University of Washington, Seattle, WA, and approved March 16, 2011 (received for review February 10, 2011) Discriminating closely related molecules remains a major challenge which SUMOylation alters protein function appears to be in the engineering of binding proteins and inhibitors. Here we through SUMO-mediated interactions with other proteins con- report the development of highly selective inhibitors of small ubi- taining a short peptide motif known as a SUMO-interacting motif quitin-related modifier (SUMO) family proteins. SUMOylation is (SIM) (4, 7, 8). involved in the regulation of diverse cellular processes. Functional There are few inhibitors of SUMO/SIM interactions, a defi- differences between two major SUMO isoforms in humans, SUMO1 ciency that limits our ability to finely dissect SUMO biology. In and SUMO2∕3, are thought to arise from distinct interactions the only reported example of such an inhibitor, a SIM-containing mediated by each isoform with other proteins containing SUMO- linear peptide was used to inhibit SUMO/SIM interactions, estab- interacting motifs (SIMs). However, the roles of such isoform- lishing their importance in coordinating DNA repair by nonho- specific interactions are largely uncharacterized due in part to the mologous end joining (9).
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Prokaryotic Ubiquitin-Like Protein Remains Intrinsically Disordered When Covalently Attached to Proteasomal Target Proteins Jonas Barandun1,2, Fred F
    Barandun et al. BMC Structural Biology (2017) 17:1 DOI 10.1186/s12900-017-0072-1 RESEARCH ARTICLE Open Access Prokaryotic ubiquitin-like protein remains intrinsically disordered when covalently attached to proteasomal target proteins Jonas Barandun1,2, Fred F. Damberger1, Cyrille L. Delley1, Juerg Laederach1, Frédéric H. T. Allain1 and Eilika Weber-Ban1* Abstract Background: The post-translational modification pathway referred to as pupylation marks proteins for proteasomal degradation in Mycobacterium tuberculosis and other actinobacteria by covalently attaching the small protein Pup (prokaryotic ubiquitin-like protein) to target lysine residues. In contrast to the functionally analogous eukaryotic ubiquitin, Pup is intrinsically disordered in its free form. Its unfolded state allows Pup to adopt different structures upon interaction with different binding partners like the Pup ligase PafA and the proteasomal ATPase Mpa. While the disordered behavior of free Pup has been well characterized, it remained unknown whether Pup adopts a distinct structure when attached to a substrate. Results: Using a combination of NMR experiments and biochemical analysis we demonstrate that Pup remains unstructured when ligated to two well-established pupylation substrates targeted for proteasomal degradation in Mycobacterium tuberculosis, malonyl transacylase (FabD) and ketopantoyl hydroxylmethyltransferase (PanB). Isotopically labeled Pup was linked to FabD and PanB by in vitro pupylation to generate homogeneously pupylated substrates suitable for NMR analysis. The single target lysine of PanB was identified by a combination of mass spectroscopy and mutational analysis. Chemical shift comparison between Pup in its free form and ligated to substrate reveals intrinsic disorder of Pup in the conjugate. Conclusion: When linked to the proteasomal substrates FabD and PanB, Pup is unstructured and retains the ability to interact with its different binding partners.
    [Show full text]
  • Yichen – Structure and Allostery of the Chaperonin Groel. Allosteric
    Literature Lunch 5-1-13 Yichen – J Mol Biol. 2013 May 13;425(9):1476-87. doi: 10.1016/j.jmb.2012.11.028. Epub 2012 Nov 24. Structure and Allostery of the Chaperonin GroEL. Saibil HR, Fenton WA, Clare DK, Horwich AL. Source Crystallography and Institute of Structural and Molecular Biology, Birkbeck College London, Malet Street, London WC1E 7HX, UK. Abstract Chaperonins are intricate allosteric machines formed of two back-to-back, stacked rings of subunits presenting end cavities lined with hydrophobic binding sites for nonnative polypeptides. Once bound, substrates are subjected to forceful, concerted movements that result in their ejection from the binding surface and simultaneous encapsulation inside a hydrophilic chamber that favors their folding. Here, we review the allosteric machine movements that are choreographed by ATP binding, which triggers concerted tilting and twisting of subunit domains. These movements distort the ring of hydrophobic binding sites and split it apart, potentially unfolding the multiply bound substrate. Then, GroES binding is accompanied by a 100° twist of the binding domains that removes the hydrophobic sites from the cavity lining and forms the folding chamber. ATP hydrolysis is not needed for a single round of binding and encapsulation but is necessary to allow the next round of ATP binding in the opposite ring. It is this remote ATP binding that triggers dismantling of the folding chamber and release of the encapsulated substrate, whether folded or not. The basis for these ordered actions is an elegant system of nested cooperativity of the ATPase machinery. ATP binds to a ring with positive cooperativity, and movements of the interlinked subunit domains are concerted.
    [Show full text]
  • SUMO and Ubiquitin in the Nucleus: Different Functions, Similar Mechanisms?
    Downloaded from genesdev.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Grace Gill1 Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA The small ubiquitin-related modifier SUMO posttrans- tin, SUMO modification regulates protein localization lationally modifies many proteins with roles in diverse and activity. processes including regulation of transcription, chroma- This review focuses on recent advances in our under- tin structure, and DNA repair. Similar to nonproteolytic standing of SUMO function and regulation, drawing on a roles of ubiquitin, SUMO modification regulates protein limited set of examples relating to gene expression, chro- localization and activity. Some proteins can be modified matin structure, and DNA repair. Comparison of SUMO by SUMO and ubiquitin, but with distinct functional and ubiquitin activities in the nucleus reveals interest- consequences. It is possible that the effects of ubiquiti- ing differences in function and suggests surprising simi- nation and SUMOylation are both largely due to binding larities in mechanism. Thus, for example, modification of proteins bearing specific interaction domains. Both of transcription factors and histones by ubiquitin is gen- modifications are reversible, and in some cases dynamic erally associated with increased gene expression whereas cycles of modification may be required for activity. Stud- modification of transcription factors and histones by ies of SUMO and ubiquitin in the nucleus are yielding SUMO is generally associated with decreased gene ex- new insights into regulation of gene expression, genome pression. In some cases, SUMO and ubiquitin may di- maintenance, and signal transduction.
    [Show full text]
  • Progress in the Discovery of Small Molecule Modulators of Desumoylation
    Curr. Issues Mol. Biol. (2020) 35: 17-34. Progress in the Discovery of Small Molecule Modulators of DeSUMOylation Shiyao Chen, Duoling Dong, Weixiang Xin and Huchen Zhou* School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China. *Correspondence: [email protected] htps://doi.org/10.21775/cimb.035.017 Abstract protein–protein interactions, gene transcription, SUMOylation and DeSUMOylation are reversible genome integrity, and DNA replication and repair protein post-translational modifcation (PTM) (Wilkinson and Henley, 2010; Vierstra, 2012; processes involving small ubiquitin-like modifer Bailey et al., 2016). In 1995, Meluh and Koshland (SUMO) proteins. Tese processes have indis- (1995) identifed Smt3 in Saccharomyces cerevi- pensable roles in various cellular processes, such siae, which is the earliest report within this fled. as subcellular localization, gene transcription, and Two years later, based on the sequence similarity DNA replication and repair. Over the past decade, between ubiquitin and a new 11.5-kDa protein, increasing atention has been given to SUMO- ubiquitin/SMT3, the name SUMO was formally related pathways as potential therapeutic targets. proposed for the frst time (Mahajan et al., 1997). Te Sentrin/SUMO-specifc protease (SENP), Although SUMO modifcation is closely which is responsible for deSUMOylation, has related to the progression of various diseases, such been proposed as a potential therapeutic target as cancers and cardiac disorders, it has aroused in the treatment of cancers and cardiac disorders. increasing atention as a potential therapeutic target Unfortunately, no SENP inhibitor has yet reached in recent years, especially concerning the Sentrin/ clinical trials. In this review, we focus on advances SUMO-specifc protease (SENP), which is the key in the development of SENP inhibitors in the past regulator of deSUMOylation.
    [Show full text]
  • Loss of Conserved Ubiquitylation Sites in Conserved Proteins During Human Evolution
    INTERNATIONAL JOURNAL OF MOleCular meDICine 42: 2203-2212, 2018 Loss of conserved ubiquitylation sites in conserved proteins during human evolution DONGBIN PARK, CHUL JUN GOH, HYEIN KIM, JI SEOK LEE and YOONSOO HAHN Department of Life Science, Chung‑Ang University, Seoul 06974, Republic of Korea Received January 30, 2018; Accepted July 6, 2018 DOI: 10.3892/ijmm.2018.3772 Abstract. Ubiquitylation of lysine residues in proteins serves Introduction a pivotal role in the efficient removal of misfolded or unused proteins and in the control of various regulatory pathways Ubiquitylation, in which the highly conserved 76‑residue poly- by monitoring protein activity that may lead to protein peptide ubiquitin is covalently attached to a lysine residue of degradation. The loss of ubiquitylated lysines may affect substrate proteins, mediates the targeted destruction of ubiq- the ubiquitin‑mediated regulatory network and result in the uitylated proteins by the ubiquitin‑proteasome system (1‑4). emergence of novel phenotypes. The present study analyzed The ubiquitin‑mediated protein degradation pathway serves a mouse ubiquitylation data and orthologous proteins from crucial role in the efficient and specific removal of misfolded 62 mammals to identify 193 conserved ubiquitylation sites from proteins and certain key regulatory proteins (5,6). Ubiquitin 169 proteins that were lost in the Euarchonta lineage leading and other ubiquitin‑like proteins, including autophagy‑related to humans. A total of 8 proteins, including betaine homo- protein 8, Ubiquitin‑like
    [Show full text]
  • Epstein-Barr Virus Viral Protein Lmp1 Increases Rap1
    EPSTEIN-BARR VIRUS VIRAL PROTEIN LMP1 INCREASES RAP1 SUMOYLATION, ENHANCING TELOMERE MAINTENANCE DURING TUMORIGENESIS By WYATT TYLER CRAMBLET B.S., Biology, Gordon State College, 2016 A Thesis Submitted to the Faculty of Mercer University School of Medicine in Partial Fulfillment of the Requirements for the Degree MASTER OF SCIENCE IN BIOMEDICAL SCIENCE Macon, GA 2018 EPSTEIN-BARR VIRUS VIRAL PROTEIN LMP1 INCREASES RAP1 SUMOYLATION, ENHANCING TELOMERE MAINTENANCE DURING TUMORIGENESIS By WYATT TYLER CRAMBLET Approved: ___________________________________________ Date _________ Gretchen L. Bentz, Ph.D. Faculty Advisor for Thesis ___________________________________________ Date _________ Richard O. McCann, Ph.D. Thesis Committee Member ___________________________________________ Date _________ Laura Silo-Suh, Ph.D. Thesis Committee Member ___________________________________________ Date _________ Jon Shuman, Ph.D. Thesis Committee Member ___________________________________________ Date _________ Jean Sumner, MD Dean, Mercer University School of Medicine ACKNOWLEDGEMENTS I would like to thank the National Institutes of Health for providing the funding for this project and Mercer University School of Medicine for the opportunity for discovery and knowledge this experience has provided me. My utmost respect and gratitude goes to Dr. Gretchen Bentz. Along the course of my research Dr. Bentz has always provided what I required to be successful: materials, focus, experience, and understanding. Her guidance at both the lab and the writing desk is what has allowed me to accomplish the greatest achievement of my academic career. I thank Dr. Richard McCann and Dr. Christy Bridges who have been the Directors of the Master of Science Biomedical Sciences Program. Their leadership has been invaluable to my peers and me for becoming the professionals we set out to be.
    [Show full text]
  • Mdm2-Mediated Ubiquitylation: P53 and Beyond
    Cell Death and Differentiation (2010) 17, 93–102 & 2010 Macmillan Publishers Limited All rights reserved 1350-9047/10 $32.00 www.nature.com/cdd Review Mdm2-mediated ubiquitylation: p53 and beyond J-C Marine*,1 and G Lozano2 The really interesting genes (RING)-finger-containing oncoprotein, Mdm2, is a promising drug target for cancer therapy. A key Mdm2 function is to promote ubiquitylation and proteasomal-dependent degradation of the tumor suppressor protein p53. Recent reports provide novel important insights into Mdm2-mediated regulation of p53 and how the physical and functional interactions between these two proteins are regulated. Moreover, a p53-independent role of Mdm2 has recently been confirmed by genetic data. These advances and their potential implications for the development of new cancer therapeutic strategies form the focus of this review. Cell Death and Differentiation (2010) 17, 93–102; doi:10.1038/cdd.2009.68; published online 5 June 2009 Mdm2 is a key regulator of a variety of fundamental cellular has also emerged from recent genetic studies. These processes and a very promising drug target for cancer advances and their potential implications for the development therapy. It belongs to a large family of (really interesting of new cancer therapeutic strategies form the focus of this gene) RING-finger-containing proteins and, as most of its review. For a more detailed discussion of Mdm2 and its other members, Mdm2 functions mainly, if not exclusively, as various functions an interested reader should also consult an E3 ligase.1 It targets various substrates for mono- and/or references9–12. poly-ubiquitylation thereby regulating their activities; for instance by controlling their localization, and/or levels by The p53–Mdm2 Regulatory Feedback Loop proteasome-dependent degradation.
    [Show full text]
  • SUMO and Transcriptional Regulation: the Lessons of Large-Scale Proteomic, Modifomic and Genomic Studies
    molecules Review SUMO and Transcriptional Regulation: The Lessons of Large-Scale Proteomic, Modifomic and Genomic Studies Mathias Boulanger 1,2 , Mehuli Chakraborty 1,2, Denis Tempé 1,2, Marc Piechaczyk 1,2,* and Guillaume Bossis 1,2,* 1 Institut de Génétique Moléculaire de Montpellier (IGMM), University of Montpellier, CNRS, Montpellier, France; [email protected] (M.B.); [email protected] (M.C.); [email protected] (D.T.) 2 Equipe Labellisée Ligue Contre le Cancer, Paris, France * Correspondence: [email protected] (M.P.); [email protected] (G.B.) Abstract: One major role of the eukaryotic peptidic post-translational modifier SUMO in the cell is transcriptional control. This occurs via modification of virtually all classes of transcriptional actors, which include transcription factors, transcriptional coregulators, diverse chromatin components, as well as Pol I-, Pol II- and Pol III transcriptional machineries and their regulators. For many years, the role of SUMOylation has essentially been studied on individual proteins, or small groups of proteins, principally dealing with Pol II-mediated transcription. This provided only a fragmentary view of how SUMOylation controls transcription. The recent advent of large-scale proteomic, modifomic and genomic studies has however considerably refined our perception of the part played by SUMO in gene expression control. We review here these developments and the new concepts they are at the origin of, together with the limitations of our knowledge. How they illuminate the SUMO-dependent Citation: Boulanger, M.; transcriptional mechanisms that have been characterized thus far and how they impact our view of Chakraborty, M.; Tempé, D.; SUMO-dependent chromatin organization are also considered.
    [Show full text]
  • Differential Effects of SUMO1/2 on Circadian Protein PER2 Stability And
    bioRxiv preprint doi: https://doi.org/10.1101/789222; this version posted August 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Title: Differential Effects of SUMO1/2 on Circadian Protein PER2 Stability and 2 Function 3 4 Author Affiliation: Ling-Chih Chen1,2, Yung-Lin Hsieh1, Tai-Yun Kuo1, Yu-Chi Chou1, Pang-Hung 5 Hsu3, Wendy W. Hwang-Verslues1,2,4* 6 1Genomics Research Center, Academia Sinica, Taipei 115, Taiwan; 7 2Graduate Institute of Life Science, National Defense Medical Center, Taipei 114, Taiwan; 8 3Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung City 202, 9 Taiwan; 10 4Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and 11 Technology, Taipei Medical University, Taipei 110, Taiwan 12 13 Corresponding Author*: Wendy W. Hwang-Verslues, Ph.D., Genomics Research Center, Academia 14 Sinica, No. 128, Sec. 2, Academia Road, Taipei 115, Taiwan. Email: [email protected], 15 Phone: +886-2-2787-1246, Fax: +886-2-2789-9924, ORCID: 0000-0002-0383-1710 16 17 Keywords: Period2/SUMO/phosphorylation/ubiquitination/circadian/post-translational modification 1 bioRxiv preprint doi: https://doi.org/10.1101/789222; this version posted August 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • How Does SUMO Participate in Spindle Organization?
    cells Review How Does SUMO Participate in Spindle Organization? Ariane Abrieu * and Dimitris Liakopoulos * CRBM, CNRS UMR5237, Université de Montpellier, 1919 route de Mende, 34090 Montpellier, France * Correspondence: [email protected] (A.A.); [email protected] (D.L.) Received: 5 July 2019; Accepted: 30 July 2019; Published: 31 July 2019 Abstract: The ubiquitin-like protein SUMO is a regulator involved in most cellular mechanisms. Recent studies have discovered new modes of function for this protein. Of particular interest is the ability of SUMO to organize proteins in larger assemblies, as well as the role of SUMO-dependent ubiquitylation in their disassembly. These mechanisms have been largely described in the context of DNA repair, transcriptional regulation, or signaling, while much less is known on how SUMO facilitates organization of microtubule-dependent processes during mitosis. Remarkably however, SUMO has been known for a long time to modify kinetochore proteins, while more recently, extensive proteomic screens have identified a large number of microtubule- and spindle-associated proteins that are SUMOylated. The aim of this review is to focus on the possible role of SUMOylation in organization of the spindle and kinetochore complexes. We summarize mitotic and microtubule/spindle-associated proteins that have been identified as SUMO conjugates and present examples regarding their regulation by SUMO. Moreover, we discuss the possible contribution of SUMOylation in organization of larger protein assemblies on the spindle, as well as the role of SUMO-targeted ubiquitylation in control of kinetochore assembly and function. Finally, we propose future directions regarding the study of SUMOylation in regulation of spindle organization and examine the potential of SUMO and SUMO-mediated degradation as target for antimitotic-based therapies.
    [Show full text]